Tandem Diabetes snags FDA approval for interoperable insulin pump software – MedCity News
Tandem Diabetes’ technology will create a new approval pathway for predictive dosing software that can be used with other devices.
Related Articles
‘It’s Not About Beauty, It’s About Privacy’: How One Cancer Survivor Is Changing Chemo Care – MedCity News
Breast cancer survivor Kate Dilligan is the CEO of Cooler Heads, a company that sells a portable and self-administered scalp cooling device. The system helps…
Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss – MedCity News
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes.…
INVEST 2025
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss – MedCity News
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes.…
Making Automation a Mainstream Function in Healthcare Practices – MedCity News
In a webinar sponsored by Jotform, scheduled for Thursday, March 13 at 2 pm ET, panelists will discuss how health tech companies approach data automation and…
Everything You Need to Know About Sterilization Cases and Their Role in Healthcare – MedCity News
Innovative sterilization cases and trays are instrumental in reducing infection risk in medical settings. Learn notable things about them and their makers.
When Dialysis Comes Home, Patients and Care Partners Flourish – MedCity News
When home dialysis is done right, care partners quickly discover they are becoming an integral part of the process as engaged, informed participants rather than…
Harnessing Innovative Transplant Diagnostics to Improve Patient Outcomes – MedCity News
Innovative transplant diagnostics and novel paradigms that give a clearer picture of a recipient’s immune system at various phases of the transplant journey can enable…
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder – MedCity News
Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for…
Inside Healthcare’s Hottest New AI Category: Agentic AI – MedCity News
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption…